Tekmira Additional Targets. Subject to Section 3.3, during the period beginning on the Effective Date and ending on the [Redacted – number] anniversary thereof, Tekmira may select (i) up to two (2) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Exclusive Target” and (ii) up to five (5) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Non-Exclusive Target”. For clarity, the Parties acknowledge that such seven (7) Tekmira Additional Targets shall be in addition to the one (1) Tekmira Exclusive Target and the five (5) Tekmira Non-Exclusive Targets selected as of the Effective Date.
Appears in 3 contracts
Samples: Cross License Agreement, Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp), Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)
Tekmira Additional Targets. Subject to Section 3.3, during the period beginning on the Effective Date and ending on the [Redacted – number**] anniversary thereof, Tekmira may select (i) up to two (2) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Exclusive Target” and (ii) up to five (5) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Non-Exclusive Target”. For clarity, the Parties acknowledge that such seven (7) Tekmira Additional Targets shall be in addition to the one (1) Tekmira Exclusive Target and the five (5) Tekmira Non-Exclusive Targets selected as of the Effective Date.
Appears in 2 contracts
Samples: Cross License Agreement (Alnylam Pharmaceuticals, Inc.), Cross License Agreement (Alnylam Pharmaceuticals, Inc.)
Tekmira Additional Targets. Subject to Section 3.3, during the period beginning on the Effective Date and ending on the [Redacted – number**] anniversary thereof, Tekmira may select (i) up to [**] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. two (2) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Exclusive Target” and (ii) up to five (5) Targets (other than the Alnylam Exclusive Targets) that shall each become a “Tekmira Additional Non-Exclusive Target”. For clarity, the Parties acknowledge that such seven (7) Tekmira Additional Targets shall be in addition to the one (1) Tekmira Exclusive Target and the five (5) Tekmira Non-Exclusive Targets selected as of the Effective Date.
Appears in 1 contract
Samples: Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)
